Podcasts about america shea

This week, Marianna sits down with John Faragon to talk about ID Week, the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP), which took place in October 2022. Learn all about what happened in this episode. --Help us track the number of listeners our episode gets by filling out this brief form!  (https://www.e2NECA.org/?r=DDT4457) 

In this episode, Dr. Sheliza Halani interviews special guest Dr. Alon Vaisman (Infectious Diseases) on the Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).They discuss the definitions of severity of C. difficile, recommendations for current treatment and testing, prophylaxis and surgical management options. Producer and Host: Dr. Sheliza HalaniGuest: Dr. Alon Vaisman (Infectious Diseases)Sound Editing: Dr. Alison LaiSupport the show

This week on Pharm5: FTC launches investigation into PBMs COVID vaccines coming soon for kids

On this episode, we review the 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults published by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).  Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:  www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

With students, faculty, and staff returning to their school systems, the question of how to keep those within these institutions safe is at the forefront of everyone's mind. Join us and our guest, Lead Clinical Editor of APIC Text Kelley Boston, for a discussion on how to get creative in adhering to CDC guidelines for returning to classrooms, acquiring community buy-in on safety precautions, and concerns surrounding routine vaccination schedules for children. Hosted by: Silvia Quevedo, CAE About our Guest: Kelley M. Boston, MPH, CIC, CPHQ, FAPIC Kelley M. Boston, MPH, CIC, CPHQ, FAPIC is an infection preventionist with nearly 20 years of experience, and brings a background in public health and epidemiology to her infection prevention practice, providing insights on team-focused change processes and disaster preparedness. Her primary expertise is in acute care settings and she has held leadership roles in multi-facility systems that have included both community hospitals and major academic teaching centers, and specialized practice areas including pediatrics, transplant, and trauma. She was honored as an APIC Hero of Infection Prevention in 2016 for her work in program integration and development within a large multi-facility healthcare system, leading to significant sustained improvement in infection outcomes. She is an active member of both the Society for Healthcare Epidemiologists of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC), where she has served as president and board member in multiple local chapters, and at the national level on the Communications Committee and APIC Text Editorial Panel. She is currently the President and Legislative representative for the Houston APIC Chapter and the Lead Clinical Editor for the APIC Text. Kelley holds a Master's of Public Health in international and family health, with a concentration in epidemiology from The University of Texas Health Science Center Houston School of Public Health. In addition, she holds a degree in Geography with a focus on environmental resources management and medical geography from The University of Texas at Austin. She holds certifications in infection prevention and control (CIC), healthcare quality (CPHQ) and is recognized as a Fellow of the Association for Professionals in Infection Control and Epidemiology (FAPIC). Back to School Safety During COVID-19

Why is Christiana Care now mandating vaccines for all employees? How safe is the vaccine in real world use? Dr. Marci Drees is the Chief Infection Prevention Officer and hospital epidemiologist for Christiana Care. She is a national expert on infectious diseases, healthcare-associated infections, and vaccines. Dr. Drees chairs the Education Committee of the Society for Healthcare Epidemiology of America (SHEA), and serves as SHEA's liaison to the CDC's Advisory Committee on Immunization Practices (ACIP). She is board certified in internal medicine and infectious diseases.

What comes to mind when you hear the word, “microbes”? If your first thought is bacteria, you may also correlate that with sickness. Surprisingly, that is not always the case. Join us and our guests, Dr. Salah Qutaishat and Dr. Timothy Wiemken, for a discussion on the importance of a well-balanced microbiome through the lens of two of their great loves: yogurt and beer. This episode exposes the microbial parallel between a brewery and a hospital, and the necessity of microbes in our day-to-day health. Hosted by: Silvia Quevedo, CAE About our Guests: Salah S. Qutaishat, PhD, CIC, FSHEA, FAPIC Salah Qutaishat, PhD, is currently a consultant in infection prevention and healthcare epidemiology. Most recently, he held the position of system director of Infection Prevention at Munson Healthcare. He is dedicated to helping healthcare organizations prevent healthcare-associated infection and antimicrobial resistance through automation and process simplification. Dr. Qutaishat received his PhD in microbiology from the SUNY at Buffalo, an MS in medical biology from Long Island University, and a BS in Biology from the University of Jordan. For the past two decades he held several positions in infection prevention and healthcare epidemiology. He is an expert in infection prevention, prevention of microbial resistance and healthcare informatics. Dr. Qutaishat is also certified in infection control (CIC) and is a fellow of the Society of Healthcare Epidemiology of America (FSHEA). He was on the clinical faculty at SUNY at Buffalo and University of Wisconsin at La Crosse. He is a member of several professional societies including the Society for Healthcare Epidemiology of America (SHEA), Association for Professionals in Infection Control and Epidemiology (APIC), Infectious Diseases Society of America (IDSA), American Society for Microbiology (ASM). Dr. Qutaishat has published numerous papers in peer-reviewed journals, he is also a reviewer for both APIC and SHEA journals. He also presented clinical findings at national and local meetings. Timothy L. Wiemken, PhD, MPH, FAPIC, FSHEA, CIC Dr. Timothy Wiemken is an Associate Professor in the Saint Louis University School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, Allergy, and Immunology. He is the Director of Infectious Diseases Epidemiology for SSM Health Saint Louis University Hospital, the Director of Data Science and Epidemiology in the Institute for Vaccine Science and Policy, and the Director of the Systems Infection Prevention Center at Saint Louis University. Dr. Wiemken has a doctorate in Public Health from the University of Louisville, a master’s degree in Epidemiology from Saint Louis University, and has a bachelor’s degree in microbiology and molecular biology from Southern Illinois University. He was previously an infection preventionist at the University of Louisville Hospital and the Hospital Epidemiologist for the Robley Rex Veterans Affairs Medical Center in Louisville, KY. He has been certified in infection prevention and control since 2008 and is a fellow of both the Association for Professionals in Infection Control and Epidemiology (APIC) and the Society for Healthcare Epidemiology of America (SHEA). He is active with APIC and the SHEA, serving on many national committees. He has authored and co-authored numerous guidelines and book chapters on infectious diseases and infection prevention, and nearly 200 peer-reviewed journal articles, book chapters, and national/international guidelines related to infectious disease epidemiology. His research currently focuses on pneumonia, influenza, emerging respiratory pathogens, data science in healthcare, and healthcare-associated infections.

Guest: Maria I. Vazquez Roque, M.D. (@MVazquezRoqueMD)  Host: Darryl S. Chutka, M.D. (@ChutkaMD)  Clostridium difficile is a toxin-producing bacterium that can result in a severe form of antibiotic-associated diarrhea known as clostridium difficile infection or CDI. Cases can vary from mild diarrhea to severe colitis that at times can be fatal. There's been a dramatic increase in the number as well as severity of CDIs in the U.S. over the past 20 years. Although CDI typically occurs following the use of antibiotics, it can also be spread from one individual to another, especially in hospitals and skilled nursing facilities. Antibiotics have been the traditional treatment for patients with CDI, however recurrent symptoms have been a problem. There's now a new treatment for CDI, felt to be effective in over 90% of patients with the illness. Our guest to discuss this topic is Dr. Maria Vazquez Roque, a gastroenterologist at the Mayo Clinic. We'll review the common presenting symptoms, laboratory tests needed to establish a diagnosis, and the current recommendations for treatment including the latest of fecal transplantation.  Additional resources:  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): https://doi.org/10.1093/cid/cix1085  Specific topics discussed: The typical presentation of C. difficile infection Patients who are at increased risk for a C. difficile infection Laboratory tests to order to confirm a case of C. difficile infection Treatment options for C. difficile infection including fecal transplantation Potential benefit of probiotics for preventing a C. difficile infection Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

On the podcast is Kelley Boston. Kelley is a Senior Associate with Infection Prevention & Management Associates.  She brings a background in public health and epidemiology to her infection prevention practice.  She holds a Masters of Public Health from The University of Texas Health Science Center Houston School of Public Health, and did her undergraduate work at The University of Texas at Austin.  She holds certifications in infection prevention and control (CIC), healthcare quality (CPHQ) and is recognized as a Fellow of the Association for Professionals in Infection Control and Epidemiology (FAPIC).   Ms. Boston's primary experience is in acute care, and has held leadership roles in multi-facility systems that have included both community hospitals and major academic teaching centers, and  specialized practice areas including pediatrics, transplant, and trauma.  She was honored as an APIC Hero of Infection Prevention in 2016 for her work in program integration and development within a large multi-facility healthcare system, leading to significant sustained improvement in infection outcomes. Ms. Boston is an active member of both the Society for Healthcare Epidemiologists of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC), where she has served as president and board member in multiple local chapters, and at the national level on the Communications Committee and APIC Text Editorial Panel.  She is currently the Editor of the APIC Text Online: APIC Text of Infection Control and Epidemiology. A few key takeaways: On resource alignmentYou got to look at the cost-benefit trade. If I do this audit, what do I have to take time away from? Nobody has enough time or enough staff. It is all about the resources. On working in Infection PreventionYou will never reach the end of your IP knowledge. And if you think you have, they will throw something like Coronavirus at you. Do not harm. Hospitals can be dangerous places. By the end of the day, someone is safer for the work you have done.On workplace cultureHow do we build a culture where we can help each other and create high performing teams? The importance of prevention (before the damage happens) – and the talk about why it is difficult to document successful prevention results. On our role as healthcare workersAt the end of the day, someone is safer for the work that you have done.Hospitals should be safe places where people come to get the medical care that they need and go home better. You will never be finished with the job. On dataGenerally, in the field about 40% looking at what happened, and 60% looking at what is happening and then all of the other daily tasks.Ask yourself, what are we collecting and how are we going to take action on it?  Connect with us on Twitter: Dr. Marco Bo Hansen @marcobohansenKelley Boston@epikelley

There is a reason we like to open windows or get outside for some "fresh air." Air quality and ventilation are a big deal when we try to stop the spread of viruses that can travel in the air. It can be daunting and scary, but fear not, because Dr. Hilary Babcock and Kate Gase, infection preventionist, break down the science of airborne and droplet disease transmission. In this episode, they inform us on the factors that determine how infectious a virus or bacteria may be given various environmental factors. They emphasize the importance of following what science tells us about preventing the spread of diseases. Hosted by: Silvia Quevedo About our Guest(s): Dr. Hilary Babcock, MD, MPH Dr. Hilary Babcock is a Professor of Medicine in the Infectious Diseases division at Washington University School of Medicine in St Louis and Medical Director of the Infection Prevention and Epidemiology Consortium and Occupational Infection Prevention for BJC HealthCare, a multi-hospital system in St Louis. She is also an associate hospital epidemiologist at Barnes Jewish Hospital. She is a fellow of the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). She is the immediate past-President of SHEA. She has been a member of HICPAC (CDC’s Healthcare Infection Control Practices Advisory Committee) since 2013 and is currently co-chair of the committee. She is a CDC funded investigator studying healthcare-associated infections and respiratory viral infections in healthcare settings. Kathleen Gase, MBA, MPH, FAPIC, CIC Kathleen (Kate) Gase is the Director of Patient Safety, Quality and Care Coordination at Barnes-Jewish St. Peters and Progress West Hospitals in the St. Louis, MO area. She has previous work experience with BJC HealthCare, the New York State Department of Health and Memorial Sloan-Kettering Cancer Center. Kate earned her undergraduate degree at Washington University in St. Louis, her Master’s in Public Health at Hunter College in New York City, and returned to Wash U to complete her MBA. She is certified in Infection Prevention and Epidemiology, a Fellow of the Association for Professionals in Infection Control and Epidemiology (APIC) and is currently serving on the APIC Board of Directors.

Today is the day we will find out the plan for Ontario's school year starting in September. RyanImgrund joins Greg to discuss. Guest: Ryan Imgrund, biostatistician and educator - Andrew Morris is a member of the anti-microbial stewartship. He got to provide input into a Sick Kids effort that would address improvements and changes that would need to be made to have a safe school reopening. He joins Greg about the document. Guest: Andrew Morris, professor of Medicine at the University of Toronto and the Medical Director of the Sinai Health System-University Health Network Antimicrobial Stewardship Program. Also currently the chair of the Antimicrobial Stewardship Committee for the Society for Hospital Epidemiology of America (SHEA) and chairs the Antimicrobial Stewardship Working Group for Accreditation Canada. - The Prime Minister will be testifying in the WE Charity Scandal today. Guest: Henry Jacek. Professor of Political Science, McMaster University - A public inquiry will be held into the Portapique mass shooting. Robert Pineo is leading a class action lawsuit against the killers estate and joins Greg to chat about the public inquiry. Guest: Robert Pineo. Patterson Law Portapique Public Inquiry continued. Guest: Lenore Zann, MP Cumberland-Colchester - Guest Host Greg Brady

Guests:  • Sara Keller, MD, MPH, MSHP – Moderator • Dawn Berndt, DNP, RN, CRNI®  Abstract:  We're all in this Together: COVID-19 Allies in Infection Prevention We've joined the Society for Healthcare Epidemiology of America (SHEA) for an episode of their Allies in Infection Prevention Podcast. This podcast series focuses on collaborative efforts, as well as opportunities for different disciplines to address and confront the COVID-19 pandemic. Take a listen to Working together to address COVID-19 Challenges. Resources: Society for Healthcare Epidemiology of America (SHEA). https://www.shea-online.org/  Infusion Nurses Society (INS). www.ins1.org 

Collaboration During COVID-19. Infusion Nurses Society in Collaboration with Society for Healthcare Epidemiology of America (SHEA). In this episode, Dr. Sara Keller and Dawn Berndt discuss a collaboration between Hospital Epidemiology and Infusion Nursing.

Dr. Jasmine Marcelin is an infectious disease doctor at the University of Nebraska Medical Center.  How did a doctor from Antigua end up in Nebraska?  Through Canada, of course!  It is an interesting story that she uses to educate us about some of the challenges and stigmas that international medical graduates face in order to practice medicine in the US.  Dr. Marcelin is an Assistant Professor of Medicine, Co-Director of Digital Innovation & Social Media Strategy and Associate Medical Director of Antimicrobial Stewardship and Infection Prevention & Control at University of Nebraska Medical Center & Nebraska Medicine. Her Antimicrobial Stewardship interests include diagnostic stewardship and ambulatory stewardship. She is a member of the Society for Healthcare Epidemiology of America (SHEA) and Infectious Diseases Society of America (IDSA). Dr. Marcelin is a member of several national medical society committees including the IDSA Medical Student Scholarship Committee, the Inclusion, Diversity, Access & Equity Taskforce, SHEA Awards committee and SHEA Journal Club Committee. She is a passionate advocate for gender and racial/ethnic diversity, inclusion and equity in medicine and contributes to Faculty Development efforts related to diversity & inclusion and social media for healthcare professionals. Dr. Marcelin received her medical degree from American University of Antigua College of Medicine and completed her Internal Medicine Residency & Infectious Diseases Fellowship at Mayo Clinic in Rochester, MN.  You can follow her work on twitter @DrJRMarcelin and on LinkedIn.   Find this and all episodes on your favorite podcast platform at PhysiciansGuidetoDoctoring.com Please be sure to leave a five star review, a nice comment and SHARE!!!

Milta Little, DO, CMD Milta Little, DO, CMD, is an Associate Professor of Medicine at St. Louis University in the Division of Geriatric Medicine. She is board certified in General Internal Medicine, with added qualifications in Geriatric Medicine. She serves the division as Program Director of the Geriatric Medicine Fellowship. Her primary scholarly interest is interprofessional health education to improve the care of the frail geriatric patient. Dr. Little has been on the St. Louis Magazine Best Doctor list since 2013. She is a Certified Medical Director and as such, has been a medical director at a number of Skilled Nursing Facilities. She served AMDA on the board of directors from 2012-2016 and from 2017 to present.   References: M. Little, "TREATING AND PREVENTING CLOSTRIDIUM DIFFICILE INFECTION IN LONG-TERM CARE FACILITIES", Managed Healthcare Connect, Nov, 2018 C. McDonald, et. al."Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)", Clinical Infectious Diseases, Volume 66, Issue 7, 19 March 2018 Leffler, DA and Lamont JT, "Clostridium difficile Infection”, New England Journal of Medicine, 2015 Lessa, FC, et. al., “Burden of Clostridium difficile Infection in the United States", New England Journal of Medicine, 2015

"HICS: The Insider's Perspective," produced by the Society for Healthcare Epidemiology of America (SHEA), discusses the Hospital Incident Command System - what HICS is, who's involved, when to activate, and why it's important. Moderator: Judith Guzman-Cottrill,DO, Professor of Pediatrics at Oregon Health & Science University and consultant for the Oregon Health Authority’s HAI Program, where she serves as the Medical Director for Ebola and Emerging Pathogen Preparedness. Panelists: Kristina Spurgeon, MPH, Emergency Manager at UC Davis Health, with experience including a decade at Kaiser Permanente specializing in emergency management. Pritish Tosh, MD, infectious diseases physician and the medical director for Emergency Management at Mayo Clinic in Rochester, MN. His prior training includes the Epidemic Intelligence Service at the Centers for Disease Control and Prevention (CDC) and as a fellow with the Center for Infectious Diseases Research and Policy (CIDRAP) at the University of Minnesota.

"Outbreak Communications," produced by the Society for Healthcare Epidemiology of America (SHEA), discusses lessons learned in communicating with healthcare personnel, patients, and others during recent infectious diseases outbreaks. Moderator: Judith Guzman-Cottrill,DO, Professor of Pediatrics at Oregon Health & Science University and consultant for the Oregon Health Authority’s HAI Program, where she serves as the Medical Director for Ebola and Emerging Pathogen Preparedness. Speaker: Zachary Rubin, MD, Specialist in Infectious Diseases and Medical Director of Clinical Epidemiology and Infection Prevention at the University of California, Los Angeles. Before coming to UCLA in 2006, he was a guest researcher at the CDC in the Division of Healthcare Quality Promotion for the last 2 years of his ID fellowship at Emory.

A few weeks ago, a post on Clay Smith’s Journal Feedabout the new IDSA C diff guidelines caught my attention (specifically, that metronidazole is no longer recommended as first line therapy). Whuut? I tweeted this and @medquestioningtweeted back, "Need to dig to see why they dropped metro in the bucket." Yes, @medquestioning, my thoughts exactly.   Mentioned in this episode ERcast 2.0launches May 1, 2018 To sign up for the new site and 1 year of free CME, click here Essentials of Emergency Medicineis just around the corner. If you can't make it to Vegas, the digital live stream is pretty sweet.     New IDSA C Diff Guideline Treatment Recommendations   Initial Episode, Non Severe (WBC ≤ 15k, creatinine < 1.5) First Line Vancomycin 125 mg PO QID for 10 days Fidaxomicin 200mg PO  BID for 10 days Second line Metronidazole 500mg TID PO for 10 days   Initial Episode, Severe (WBC >15k, creatinine >1.5) Vancomycin 125 mg PO QID for 10 days Fidaxomicin 200mg PO  BID for 10 days   Initial Episode, Fulminant (Hypotension or shock, ileus, megacolon) Vancomycin 500 mg 4 times per day by mouth or by nasogastric tube. If ileus, consider adding rectal instillation of vancomycin. Intravenously administered metronidazole (500 mg every 8 hours) should be administered together with oral or rectal vancomycin, particularly if ileus is present   First Recurrence • Vancomycin 125 mg given 4 times daily for 10 days if metronidazole was used for the initial episode, OR • Use a prolonged tapered and pulsed vancomycin regimen if a standard regimen was used for the initial episode (eg, 125 mg 4 times per day for 10–14 days, 2 times per day for a week, once per day for a week, and then every 2 or 3 days for 2–8 weeks), OR •  Fidaxomicin 200 mg given twice daily for 10 days if Vancomycin was used for the initial episode     Photo Credit Photo by Gabor Monori on Unsplash     The Guidelines McDonald, L. Clifford, et al. "Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)." Clinical Infectious Diseases66.7 (2018): e1-e48. PMID:29462280 Original Studies Teasley, DavidG, et al. "Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis." The Lancet322.8358 (1983): 1043-1046. PMID:6138597 Wenisch, C., et al. "Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile—associated diarrhea." Clinical infectious diseases22.5 (1996): 813-818. PMID:8722937 New Evidence Favoring Vancomycin Zar, Fred A., et al. "A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile–associated diarrhea, stratified by disease severity." Clinical Infectious Diseases45.3 (2007): 302-307. PMID:17599306 Johnson, Stuart, et al. "Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials." Clinical Infectious Diseases 59.3 (2014): 345-354. PMID: 24799326 CDC C. Diff Statistics   New York Times article on the association of the rise of new sweeteners and the rise of C. diff. The Germs That Love Diet Soda

The Infectious Diseases Society of America's Guideline Update provides concise summaries of the most important IDSA guidelines. This podcast discusses the Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) published in Clinical Infectious Diseases. For details of the guidelines presented, please go to www.idsociety.org or see the full article in Clinical Infectious Diseases 2018. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College,Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health L. Clifford McDonald, MD, Associate Director for Science, Division of Healthcare Quality Promotion, Centers for Disease Control, Atlanta, Georgia

The last podcast in the series "Stewardship: Practical Approaches and Applications", produced by the Society for Healthcare Epidemiology of America (SHEA). This episode focuses on how to impact antibiotic prescribing practices using Antimicrobial Stewardship Interventions targeting providers and patients in the outpatient setting. Panelists: Debra Palazzi, MD, MEd, Associate Professor of Pediatrics in the Infectious Diseases Section at Baylor College of Medicine, and the Medical Director of the Antimicrobial Stewardship Program at Texas Children’s Hospital; and Ellen Wald, MD, Professor and Chair of the Department of Pediatrics at the University of Wisconsin School of Medicine and Public Health and an internationally recognized expert on the diagnosis and treatment of pediatric infectious diseases.

The third podcast of the series “Stewardship: Practical Approaches and Applications”, produced by the Society for Healthcare Epidemiology of America (SHEA). This episode focuses on the leading cause of antibiotic use with UTI over diagnosis in the Adult and Pediatric populations.

The second podcast of the series "Stewardship: Practical Approaches and Applications", produced by the Society for Healthcare Epidemiology of America (SHEA). This episode focuses on integrating technological and sociobehavioral approaches to diagnostic stewardship, with a specific focus on improving blood culture ordering practices.

The first podcast of the series "Stewardship: Practical Approaches and Applications", produced by the Society for Healthcare Epidemiology of America (SHEA). This episode focuses on demonstrating how to impact the rates of Clostridium Difficile infections using antimicrobial stewardship interventions targeting providers in various practice settings. Panelists: Libby S Dodds-Ashley, PharmD, MHS with the Duke Antimicrobial Stewardship Outreach Network, and Dr. Larissa May, MD, MSHS, MSPH, an Associate Professor and Director of Emergency Department Antibiotic Stewardship at UC Davis Health System.